| 臺大學術典藏 |
2021-01-28T01:06:26Z |
Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice
|
Lin W.-H.; Yeh S.-H.; KUN-HUEI YEH; Chen K.-W.; Cheng Y.-W.; Su T.-H.; Jao P.; Ni L.-C.; Chen P.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-01-28T01:06:27Z |
Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study
|
Chen K.-H.; Shao Y.-Y.; Chen H.-M.; Lin Y.-L.; Lin Z.-Z.; Lai M.-S.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:27Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Chang Y.-L.;Kun-Huei Yeh;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:27Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang S.-H.; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; KUN-HUEI YEH; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:28Z |
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome
|
Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; KUN-HUEI YEH; Jeng Y.-M. |
| 臺大學術典藏 |
2021-01-28T01:06:28Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Guo J.-C.;Huang T.-C.;Lin C.-C.;Hsieh M.-S.;Chang C.-H.;Huang P.-M.;Lee J.-M.;Hsu F.-M.;Cheng J.C.-H.;Wang H.-P.;Kun-Huei Yeh;Cheng A.-L.;Hsu C.-H.; Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; KUN-HUEI YEH; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:28Z |
Case report: Mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistance
|
Chen K.-H.; Yuan C.-T.; Tseng L.-H.; Shun C.-T.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:29Z |
Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan
|
Shao Y.-Y.; Hsu C.-H.; KUN-HUEI YEH; Chen H.-M.; Yeh Y.-C.; Lai C.-L.; Lin Z.-Z.; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2021-01-28T01:06:29Z |
Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma
|
Li C.-L.;Kun-Huei Yeh;Liu W.-H.;Chen C.-L.;Chen D.-S.;Chen P.-J.;Yeh S.-H.; Li C.-L.; KUN-HUEI YEH; Liu W.-H.; Chen C.-L.; Chen D.-S.; Chen P.-J.; Yeh S.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:29Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Kun-Huei Yeh; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:30Z |
Young patients with colorectal cancer have increased risk of second primary cancers
|
Liang Y.-H.; Shao Y.-Y.; Chen H.-M.; Lai C.-L.; Lin Z.-Z.; Kuo R.N.; Cheng A.-L.; KUN-HUEI YEH; Lai M.-S. |
| 臺大學術典藏 |
2021-01-28T01:06:30Z |
Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; KUN-HUEI YEH; Chen L.-T.; Lin C.-W.; Hsu P.-N.; Wu M.-S.; Liou J.-M.; Tsai H.-J.; Tzeng Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:31Z |
Phase i study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
|
Chang T.C.; Shiah H.S.; Yang C.H.; KUN-HUEI YEH; Cheng A.L.; Shen B.N.; Wang Y.W.; Yeh C.G.; Chiang N.J.; Chang J.Y.; Chen L.T. |
| 臺大學術典藏 |
2021-01-28T01:06:31Z |
Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: A multicenter prospective Phase II trial
|
Hsieh J.C.; Hsu C.-L.; Ng S.-H.; Wang C.-H.; Lee K.-D.; Lu C.-H.; Chang Y.-F.; Hsieh R.-K.; KUN-HUEI YEH; Hsiao C.-H.; Chen S.-Y.; Shiau C.-Y.; Wang H.-M. |
| 臺大學術典藏 |
2021-01-28T01:06:31Z |
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): A randomised, double-blind, placebo-controlled, phase 3 trial
|
Li J.; Qin S.; Xu R.; Yau T.C.C.; Ma B.; Pan H.; Xu J.; Bai Y.; Chi Y.; Wang L.; KUN-HUEI YEH; Bi F.; Cheng Y.; Le A.T.; Lin J.-K.; Liu T.; Ma D.; Kappeler C.; Kalmus J.; Kim T.W. |
| 臺大學術典藏 |
2021-01-28T01:06:31Z |
Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN - A randomized, phase III study
|
Satoh T.;Doi T.;Ohtsu A.;Tsuji A.;Omuro Y.;Mukaiyama A.;Kobayashi M.;Miwa H.;Xu R.-H.;Sun G.-P.;Xu J.-M.;Wang J.-W.;Li J.;Qin S.-K.;Feng J.-F.;Chung H.C.;Bang Y.-J.;Chung I.-J.;Kun-Huei Yeh; Satoh T.; Doi T.; Ohtsu A.; Tsuji A.; Omuro Y.; Mukaiyama A.; Kobayashi M.; Miwa H.; Xu R.-H.; Sun G.-P.; Xu J.-M.; Wang J.-W.; Li J.; Qin S.-K.; Feng J.-F.; Chung H.C.; Bang Y.-J.; Chung I.-J.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:32Z |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity
|
Kuo S.-H.;Kun-Huei Yeh;Chen L.-T.;Lin C.-W.;Hsu P.-N.;Hsu C.;Wu M.-S.;Tzeng Y.-S.;Tsai H.-J.;Wang H.-P.;Cheng A.-L.; Kuo S.-H.; KUN-HUEI YEH; Chen L.-T.; Lin C.-W.; Hsu P.-N.; Hsu C.; Wu M.-S.; Tzeng Y.-S.; Tsai H.-J.; Wang H.-P.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:32Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.; Su W.-C.; Yen C.-J.; Hsu C.-H.; Su W.-P.; KUN-HUEI YEH; Lu Y.-S.; Cheng A.-L.; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:32Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.;Liang Y.-H.;Tsai J.-H.;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Kun-Huei Yeh;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:33Z |
Molecular-targeted therapy for chemotherapy-refractory gastric cancer: A case report and literature review
|
Kuo H.-Y.;Kun-Huei Yeh; Kuo H.-Y.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:33Z |
Unmet supportive care needs of patients with colorectal cancer: Significant differences by type D personality
|
Shun S.-C.;Kun-Huei Yeh;Liang J.-T.;Huang J.;Chen S.-C.;Lin B.-R.;Lee P.-H.;Lai Y.-H.; Shun S.-C.; KUN-HUEI YEH; Liang J.-T.; Huang J.; Chen S.-C.; Lin B.-R.; Lee P.-H.; Lai Y.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:33Z |
Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse
|
Kuo S.-H.;Tsai H.-J.;Weng W.-H.;Li C.-C.;Kun-Huei Yeh;Chen L.-T.;Cheng A.-L.; Kuo S.-H.; Tsai H.-J.; Weng W.-H.; Li C.-C.; KUN-HUEI YEH; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:34Z |
Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers
|
Kao H.-F.; Chen I.-C.; Hsu C.; Chang S.-Y.; Chien S.-F.; Chen Y.-C.; Hu F.-C.; Yang J.C.-H.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:34Z |
Type 2 diabetes mellitus is associated with increased mortality in chinese patients receiving curative surgery for colon cancer
|
Chen K.-H.;Shao Y.-Y.;Lin Z.-Z.;Yeh Y.-C.;Wen-Yi S.;Kuo R.N.;Chen H.-M.;Lai C.-L.;Kun-Huei Yeh;Cheng A.-L.;Lai M.-S.; Chen K.-H.; Shao Y.-Y.; Lin Z.-Z.; Yeh Y.-C.; Wen-Yi S.; Kuo R.N.; Chen H.-M.; Lai C.-L.; KUN-HUEI YEH; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2021-01-28T01:06:34Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen Y.-C.;Li C.-P.;Yen C.-J.;Hsu C.;Lin Y.-L.;Lin Z.-Z.;Chen L.-T.;Su W.-C.;Chao Y.;Kun-Huei Yeh;Cheng A.-L.; Shen Y.-C.; Li C.-P.; Yen C.-J.; Hsu C.; Lin Y.-L.; Lin Z.-Z.; Chen L.-T.; Su W.-C.; Chao Y.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:35Z |
Management of gastric cancer in Asia: Resource-stratified guidelines
|
Shen L.;Shan Y.-S.;Hu H.-M.;Price T.J.;Sirohi B.;Kun-Huei Yeh;Yang Y.-H.;Sano T.;Yang H.-K.;Zhang X.;Park S.R.;Fujii M.;Kang Y.-K.;Chen L.-T.; Shen L.; Shan Y.-S.; Hu H.-M.; Price T.J.; Sirohi B.; KUN-HUEI YEH; Yang Y.-H.; Sano T.; Yang H.-K.; Zhang X.; Park S.R.; Fujii M.; Kang Y.-K.; Chen L.-T. |
| 臺大學術典藏 |
2021-01-28T01:06:35Z |
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
|
Chao Y.;Hsieh J.-S.;Yeh H.-T.;Su Y.-C.;Wu C.-C.;Chen J.-S.;Tai C.-J.;Bai L.-Y.;Kun-Huei Yeh;Su W.-C.;Li C.-P.; Chao Y.; Hsieh J.-S.; Yeh H.-T.; Su Y.-C.; Wu C.-C.; Chen J.-S.; Tai C.-J.; Bai L.-Y.; KUN-HUEI YEH; Su W.-C.; Li C.-P. |
| 臺大學術典藏 |
2021-01-28T01:06:35Z |
ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers
|
Liu W.-H.;Chen C.-H.;Kun-Huei Yeh;Li C.-L.;Wu Y.-J.;Chen D.-S.;Chen P.-J.;Yeh S.-H.; Liu W.-H.; Chen C.-H.; KUN-HUEI YEH; Li C.-L.; Wu Y.-J.; Chen D.-S.; Chen P.-J.; Yeh S.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:36Z |
Everolimus for previously treated advanced gastric cancer: Results of the randomized, double-blind, phase III GRANITE-1 study
|
Ohtsu A.;Ajani J.A.;Bai Y.-X.;Bang Y.-J.;Chung H.-C.;Pan H.-M.;Sahmoud T.;Shen L.;Kun-Huei Yeh;Chin K.;Muro K.;Kim Y.H.;Ferry D.;Tebbutt N.C.;Al-Batran S.-E.;Smith H.;Costantini C.;Rizvi S.;Lebwohl D.;Van Cutsem E.; Ohtsu A.; Ajani J.A.; Bai Y.-X.; Bang Y.-J.; Chung H.-C.; Pan H.-M.; Sahmoud T.; Shen L.; KUN-HUEI YEH; Chin K.; Muro K.; Kim Y.H.; Ferry D.; Tebbutt N.C.; Al-Batran S.-E.; Smith H.; Costantini C.; Rizvi S.; Lebwohl D.; Van Cutsem E. |
| 臺大學術典藏 |
2021-01-28T01:06:36Z |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy
|
Chen W.-W.;Lin C.-C.;Huang T.-C.;Cheng A.-L.;Kun-Huei Yeh;Hsu C.-H.; Chen W.-W.; Lin C.-C.; Huang T.-C.; Cheng A.-L.; KUN-HUEI YEH; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:37Z |
Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significance
|
Kuo S.-H.;Chen L.-T.;Lin C.-W.;Wu M.-S.;Hsu P.-N.;Tsai H.-J.;Chu C.-Y.;Tzeng Y.-S.;Wang H.-P.;Kun-Huei Yeh;Cheng A.-L.; Kuo S.-H.; Chen L.-T.; Lin C.-W.; Wu M.-S.; Hsu P.-N.; Tsai H.-J.; Chu C.-Y.; Tzeng Y.-S.; Wang H.-P.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:37Z |
Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients
|
Chen I.C.;Hsu C.;Chen Y.C.;Chien S.F.;Kao H.F.;Chang S.Y.;Hu F.C.;Kun-Huei Yeh; Chen I.C.; Hsu C.; Chen Y.C.; Chien S.F.; Kao H.F.; Chang S.Y.; Hu F.C.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:37Z |
No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A reply
|
Kuo S.-H.;Weng W.-H.;Kun-Huei Yeh;Chen L.-T.;Cheng A.-L.; Kuo S.-H.; Weng W.-H.; KUN-HUEI YEH; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:37Z |
Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice
|
Lin W.-H.;Yeh S.-H.;Yang W.-J.;Kun-Huei Yeh;Fujiwara T.;Nii A.;Chang S.S.-C.;Chen P.-J.; Lin W.-H.; Yeh S.-H.; Yang W.-J.; KUN-HUEI YEH; Fujiwara T.; Nii A.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2021-01-28T01:06:38Z |
High-dose tamoxifen plus ifosfamide and anthracycline in a patient with angiosarcoma of the breast
|
Hsiao C.-H.;Kun-Huei Yeh;Chang Y.-C.;Tsai C.-C.; Hsiao C.-H.; KUN-HUEI YEH; Chang Y.-C.; Tsai C.-C. |
| 臺大學術典藏 |
2021-01-28T01:06:38Z |
erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5)
|
Hsu C.;Shen Y.-C.;Cheng C.-C.;Cheng A.-L.;Hu F.-C.;Kun-Huei Yeh; Hsu C.; Shen Y.-C.; Cheng C.-C.; Cheng A.-L.; Hu F.-C.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:38Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.;Liau J.-Y.;Yu S.-C.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Chang Y.-L.;Kun-Huei Yeh;Cheng A.-L.; Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:39Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:39Z |
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer
|
Lu L.-C.; Shao Y.-Y.; Hsu C.-H.; Hsu C.; Cheng W.-F.; Lin Y.-L.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:39Z |
Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression
|
Hsu C.; Shen Y.-C.; Cheng C.-C.; Cheng A.-L.; Hu F.-C.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:40Z |
Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4α
|
Wang S.-H.; Yeh S.-H.; Lin W.-H.; KUN-HUEI YEH; Yuan Q.; Xia N.-S.; Chen D.-S.; Chen P.-J. |
| 臺大學術典藏 |
2021-01-28T01:06:40Z |
T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement
|
Kuo S.-H.;Cheng A.-L.;Lin C.-W.;Hsu C.-H.;Wu M.-S.;Kun-Huei Yeh;Tzeng Y.-S.;Chen L.-T.; Kuo S.-H.; Cheng A.-L.; Lin C.-W.; Hsu C.-H.; Wu M.-S.; KUN-HUEI YEH; Tzeng Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2021-01-28T01:06:40Z |
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas
|
Kuo S.-H.; KUN-HUEI YEH; Wu M.-S.; Lin C.-W.; Hsu P.-N.; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:41Z |
Depletion of β-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development
|
Wang E.-Y.;Yeh S.-H.;Tsai T.-F.;Huang H.-P.;Jeng Y.-M.;Lin W.-H.;Chen W.-C.;Kun-Huei Yeh;Chen P.-J.;Chen D.-S.; Wang E.-Y.; Yeh S.-H.; Tsai T.-F.; Huang H.-P.; Jeng Y.-M.; Lin W.-H.; Chen W.-C.; KUN-HUEI YEH; Chen P.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-01-28T01:06:41Z |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen J.-S.;Chao Y.;Hsieh R.-K.;Cheng A.-L.;Chen P.-M.;Chiou T.-J.;Chao T.-Y.;Kun-Huei Yeh;Chen L.-T.;Whang-Peng J.; Chen J.-S.; Chao Y.; Hsieh R.-K.; Cheng A.-L.; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; KUN-HUEI YEH; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-01-28T01:06:41Z |
Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphoma
|
Kuo S.-H.;Weng W.-H.;Chen Z.-H.;Hsu P.-N.;Wu M.-S.;Lin C.-W.;Jeng H.-J.;Kun-Huei Yeh;Tsai H.-J.;Chen L.-T.;Cheng A.-L.; Kuo S.-H.; Weng W.-H.; Chen Z.-H.; Hsu P.-N.; Wu M.-S.; Lin C.-W.; Jeng H.-J.; KUN-HUEI YEH; Tsai H.-J.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:42Z |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001
|
Kuo S.-H.;Hsu C.-H.;Chen L.-T.;Lu Y.-S.;Lin C.-H.;Yeh P.-Y.;Jeng H.-J.;Gao M.;Kun-Huei Yeh;Cheng A.-L.; Kuo S.-H.; Hsu C.-H.; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:42Z |
Recent advances in the treatment of metastatic colorectal cancer in Taiwan
|
Lin Y.-L.;Kun-Huei Yeh;Cheng A.-L.; Lin Y.-L.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:42Z |
Personality trait and quality of life in colorectal cancer survivors
|
Shun S.-C.;Hsiao F.-H.;Lai Y.-H.;Liang J.-T.;Kun-Huei Yeh;Huang J.; Shun S.-C.; Hsiao F.-H.; Lai Y.-H.; Liang J.-T.; KUN-HUEI YEH; Huang J. |
| 臺大學術典藏 |
2021-01-28T01:06:42Z |
Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers
|
Ho Y.-F.;Lu W.-C.;Chen R.R.-L.;Cheng A.-L.;Kun-Huei Yeh; Ho Y.-F.; Lu W.-C.; Chen R.R.-L.; Cheng A.-L.; KUN-HUEI YEH |
